CLOD yields 1.86% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, CLOD + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CLOD + PFE for your $10,000?
CLOD seeks to emulate the performance of the Solactive Cloud Computing Index, representing companies in cloud computing across developed markets. The index starts from a universe of small-, mid-, and large-cap companies that may be classified within defined sub-industries of the cloud computing industry. Security selection is based on the free float market capitalization of all eligible securities with firms ranking at the top of each sub-industry chosen. Twenty companies from internet infrastructure software and data support software, 10 each from digital security software, data infrastructure software, and data architecture software industries, and 3 from e-commerce infrastructure software are considered where the top 50 securities by market-cap are selected for the index. Constituents are also weighted according to their free float market capitalization with a 4.5% cap placed on individual securities. This is to ensure diversification and to limit overconcentration. CLOD is rebalanced quarterly.
Full CLOD Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.